Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

HIGHTIDE-B

3.330
+0.0601.83%
Volume:2.42M
Turnover:7.82M
Market Cap:1.71B
PE:-3.64
High:3.400
Open:3.280
Low:3.110
Close:3.270
Loading ...
OverviewCompanyNewsFilings

BRIEF-Hightide Therapeutics Updates On Phase 3 Trials Of Berberine Ursodeoxycholate

Reuters
·
15 Apr

HighTide Therapeutics Inc - Two Phase 3 Trials of Berberine Ursodeoxycholate Met Their Primary Endpoints and Gated Secondary Endpoints

THOMSON REUTERS
·
15 Apr

Here's Why We're Watching HighTide Therapeutics' (HKG:2511) Cash Burn Situation

Simply Wall St.
·
21 Jan

HighTide Therapeutics Enrolls Patients for Phase 3 Clinical Trial of Metabolic, Digestive Diseases Drug

MT Newswires Live
·
02 Jan

HighTide Therapeutics to Cooperate on Chronic Diseases, Longevity, Anti-Aging with SSY Group

MT Newswires Live
·
19 Dec 2024

HighTide Therapeutics - Unit Entered Into Strategic Co-Operation Framework Agreement With Shijiazhuang No. 4 Pharmaceutical

THOMSON REUTERS
·
19 Dec 2024

Analyst Rate

 
 
 
 

Corporate Actions

Financial Report Announcement
Mar 28, 2025 Post Market
Financial Report Announcement
Aug 28, 2024 Post Market
Financial Report Announcement
Mar 27, 2024

Dividend History

no data

No relevant data is available

Valuation Analysis

-4.07
Current
-2.56
Sector Average
19.17%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-4.07
Maximum
-0.52
+1 STD
0.07
Minimum
-9.10
-1 STD
-5.19
Average
-2.56

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.